Compliance with recommended prophylaxis for venous thromboembolism: Improving the use and rate of uptake of clinical practice guidelines

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 2, 2004, Pages 221-227

  Kakkar, Ajay K ^a   Davidson, B L ^b   Haas, S K ^c   Büller, Harry R ^d   Levine, Mark ^e   Arcelus, Juan I ^f   Cushner, Fred D ^g   Decousus, Hervé ^h   Greer, Ian A ⁱ   Piovella, Franco ^j   Rickles, Frederick R ^k   Tapson, Victor F ^l  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e MCMASTER UNIVERSITY   (Canada)

^f Especialidad en Oftalmología Hospital Comarcal de la Axarquía Vélez Málaga Málaga   (Spain)

^g BETH ISRAEL MEDICAL CENTER   (United States)

^h SERVICE DE NEUROLOGIE   (France)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^k GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^l DUKE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Compliance; Guidelines; Thromboprophylaxis; Venous thromboembolism

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BLEEDING TENDENCY; CLINICAL PRACTICE; COMPRESSION THERAPY; DRUG EFFICACY; DRUG USE; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN; ORTHOPEDIC SURGERY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; TRAUMATOLOGY; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM; COOPERATION; PREMEDICATION; THROMBOEMBOLISM; VEIN THROMBOSIS;

COOPERATIVE BEHAVIOR; HUMANS; PRACTICE GUIDELINES; PREMEDICATION; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 4644353857     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7933.2004.00588.x     Document Type: Review

References (34)

1. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 2000; 355: 103-6.
2. Cluzeau FA, Littlejohns P, Grimshaw JM, Feder G, Moran SE. Development and application of a generic methodology to assess the quality of clinical guidelines. Int J Qual Health Care 1999; 11 21-8.
3. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB. Prevention of venous thromboembolism. Chest 2001; 119: 132S-75S.
4. Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism. An evaluation of the Use of Thromboprophylaxis guidelines. Chest 2001; 120: 1964-71.
5. Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R, Kalodiki E, Myers K, Samama M, Sasahara A. Prevention of venous thromboembolism. International Consensus Statement Guidelines compiled in accordance with the scientific evidence. Int Angiol 2001; 20: 1-37.
6. Bratzler DW, Raskob GE, Murray CK, Bumpus LJ, Piatt DS. Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting. Arch Intern Med 1998; 158: 1909-12.
7. Stratton MA, Anderson FA, Bussey HI, Caprini J, Comerota A, Haines ST, Hawkins DW, O'Connell MB, Smith RC, Stringer KA. Prevention of venous thromboembolism. Adherence to the 1995 American College of Chest Physicians Consensus Guidelines for surgical patients. Arch Intern Med 2000; 160: 334-40.
8. Anderson FA Jr, Audet A-M, St John R. Practices in the prevention of venous thromboembolism. J Thromb Thrombol 1998; 5 S7-S11.
9. Morris GK. Prevention of venous thromboembolism. A survey of methods used by orthopedic and general surgeons. Lancet 1980; ii 572-4.
10. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med 1991; 115: 581-5.
11. Francis RM, Brenkel IJ. Survey of use of thromboprophylaxis for routine total hip replacement by British orthopedic surgeons. Br J Hosp Med 1997; 57: 427-31.
12. Janku GV, Paiement GD, Green HD. Prevention of venous thromboembolism in orthopaedics in the United States. Clin Orthop Rel Res 1996; 325: 313-21.
13. Samama MM, Cohen AT, Darmon J-Y, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson C-G, Turpie AG, Weisslinger N for the Prophylaxis in Medical Patients with Enoxaparin Study Group. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999; 341: 793-800.
14. Fraisse F, Holzapfel L, Coulaud J-M, Simonneau G, Bedock B, Feissel M, Herbecq P, Pordes R, Poussel J-F, Roux L and the Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med 2000; 161: 1109-14.
15. Ageno W, Squizzata A, Ambrosini F, Dentali F, Marchesi C, Mera V, Steidl L, Venco A. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 2002; 87: 746-50.
16. Anderson FA Jr, White K for the Hip and Knee Registry Investigators. Prolonged prophylaxis in orthopedic surgery: insights from the United States. Sem Thromb Hemost 2002; 28(Suppl. 3): 43-6.
17. Ahmad HA, Geissler A, Maclellan DG. Deep venous thrombosis prophylaxis: are guidelines being followed? Aus NZ J Surg 2002; 72: 331-4.
18. Unwin AJ, Harries WJ, Jones JR. Current UK opinion on thromboprophylaxis in orthopedic surgery: its use in routine total hip and knee arthroplasty. Ann R Coll Surg Engl 1995; 77: 351-4.
19. Caprini JA, Arcelus JI, Hoffman K, Mattern T, Laubach M, Size GP, Traverso CI, Coats R. Prevention of venous thromboembolism in North America: results of a survey among general surgeons. J Vasc Surg 1994; 20: 751-8.
20. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999; 281: 1900-5.
21. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med 1993; 329: 1271-4.
22. Laverick MD, Croal SA, Mollan RAB. Orthopedic surgeons and thromboprophylaxis. Br Med J 1991; 303: 549-50.
23. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud P-AC, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.
24. Conti S, Daschbach M. Venous thromboembolism prophylaxis. A survey of its use in the United States. Arch Surg 1982; 117: 1036-40.
25. Owen TD, Coorsh J. The use of thromboprophylaxis in total hip replacement surgery: are the attitudes of orthopedic surgeons changing? J Roy Soc Med 1992; 85: 679-81.
26. Prentice C. Thromboprophylaxis in elective orthopedic surgery - what is the purpose? J Bone Joint Surg 1997; 79-B: 889-90.
27. Murray DW, Britton AR, Bulstrode CJK. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg 1996; 78-B 863-70.
28. Prentice CRM. Are symptomatic endpoints acceptable in venous thromboprophylactic studies? Haemostasis 1998; 28(Suppl. 3 : 109-12.
29. Winkler JD, Lohr KN, Brook RH. Persuasive communication and medical technology assessment. Arch Intern Med 1985; 145: 314-7.
30. Lomas J, Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J. Opinion leaders vs audit and feedback to implement practice guidelines: delivery after previous cesarean section. JAMA 1991; 265: 2202-7.
31. Williams HR, Macdonald DA. Audit of thromboembolic prophylaxis in hip and knee surgery. Ann R Coll Surg Engl 1997; 79: 55-7.
32. Durieux P, Nizard R, Ravaud P, Mounier N, Lepage E. A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA 2000; 283 2816-21.
33. Phillips WS, Smith J, Greaves M, Preston FE, Channer KS. An evaluation and improvement program for inpatient anticoagulant control. Thromb Haemost 1997; 77: 283-8.
34. http://www.inate.org. Accessed 29 January 2003.